Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertrophic cardiomyopathy.

P Capek1, R Brdicka

  • 1Department of Anthropology and Human Genetics, Charles University, Prague. pcapek@email.cz

Casopis Lekaru Ceskych
|March 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncolytic viruses and cancer treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2023
Same author

Reconstructing the microstructure of polyimide-silicalite mixed-matrix membranes and their particle connectivity using FIB-SEM tomography.

Journal of microscopy·2017
Same author

The antiviral potency of Fagus sylvatica 4OMe-glucuronoxylan sulfates.

International journal of biological macromolecules·2016
Same author

Characterization and pharmacodynamic properties of Arnica montana complex.

International journal of biological macromolecules·2014
Same author

The cough suppressive activity of sulfated glucuronoxylan from Fagus sylvatica L.

International journal of biological macromolecules·2014
Same author

Serum levels of matrix metalloproteinases 2 and 9 and TGFBR2 gene screening in patients with ascending aortic dilatation.

Folia biologica·2013
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Hypertrophic cardiomyopathy is a complex genetic heart condition often caused by mutations in sarcomeric protein genes. Research identifies numerous genetic mutations contributing to this disease

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a multigenetic cardiac disease.
  • It typically follows an autosomal dominant inheritance pattern with incomplete penetrance.
  • HCM is primarily caused by mutations in genes encoding sarcomeric contractile proteins.

Purpose of the Study:

  • To review the genetic basis of hypertrophic cardiomyopathy.
  • To identify genes associated with sarcomeric and non-sarcomeric proteins implicated in HCM.
  • To highlight the complex genetic landscape of HCM.

Main Methods:

  • Literature review of genetic mutations associated with hypertrophic cardiomyopathy.
  • Analysis of mutations in genes encoding thick filament proteins (e.g., beta myosin heavy chain).

Related Experiment Videos

  • Analysis of mutations in genes encoding thin filament proteins (e.g., cardiac actin, troponins, tropomyosin).
  • Inclusion of mutations in sarcomeric cytoskeletal proteins (e.g., titin) and non-sarcomeric proteins.

    • Main Results:

    • Mutations identified in genes for thick filament proteins: beta myosin heavy chain, myosin light chains, and cardiac myosin binding protein-C.
    • Mutations identified in genes for thin filament proteins: cardiac actin, cardiac troponin T, cardiac troponin C, cardiac troponin I, and alpha-tropomyosin.
    • Mutations in the sarcomeric cytoskeletal protein titin are also implicated.
    • Mutations in non-sarcomeric proteins contribute to non-pure forms of HCM.

    Conclusions:

    • Hypertrophic cardiomyopathy results from mutations in a wide array of sarcomeric protein genes.
    • Genetic heterogeneity extends to non-sarcomeric proteins, contributing to diverse clinical presentations.
    • HCM is a complex cardiac disease with varied genetic underpinnings and clinical features.